Cerefolin NAC

Where this label comes from

An original label of the NIH's Dietary Supplement Label Database, entered there on 23 August 2019, shown here as it was entered. The NIH's record

General information

Product name

Cerefolin NAC

Brand

Alfasigma

Barcode (UPC)

Not printed

Net contents

90 Caplet(s)

Market status

On market

DSLD ID

206099

Classification

Supplement form

Other (e.g. tea bag)

Product type

Other Combinations

Claim types on the label

Nutrient, All Other, Structure/Function

Intended for

Adult (18 - 50 Years), Women (not pregnant or lactating), Gluten Free

Label statements

Formula: Contains: Contains milk and soy

Precautions: Allergies: Contains milk and soy

Formulation: Does NOT Contain: CerefolinNAC caplets do not contain lactose, yeast or gluten.

Precautions: All Other: CerefolinNAC is a prescription medical food for use only under the supervision of a physician.

Precautions: All Other: Medical foods are intended for a patient who has a limited or impaired capacity to ingest, digest, absorb, or metabolize ordinary foodstuffs or certain nutrients, or who has other special medically determined nutrient requirements, the dietary management of which cannot be achieved by the modification of the normal diet alone.

Precautions: All Other: Contraindications CerefolinNAC is contraindicated in patients with known hypersensitivity to any of the components contained in this product.

Precautions: All Other: Precautions General Folic acid, when administered in daily doses above 0.1mg, may obscure the detection of B12 deficiency (specifically, the administration of folic acid may reverse the hematological manifestations of B12 deficiency, including pernicious anemia, while not addressing the neurological manifestations). L-methylfolate Calcium may be less likely than folic acid to mask vitamin B12 deficiency. Folate therapy alone is inadequate for the treatment of a B12 deficiency.

Precautions: Pregnant or Nursing or Prescription Medications: N-acetyl-L-cysteine should be avoided by nursing mothers.

Precautions: Children: N-acetyl-L-cysteine clearance is reduced in those with chronic liver disease as well as in pre-term newborns.

Precautions: All Other: Headaches may be intensified in those taking N-acetyl-L-cysteine and nitrates for the treatment of angina.24 While the incidence of renal stones is low, those that do form renal stones, particularly cysteine stones should avoid CerefolinNAC. Do not administer CerefolinNAC to critically ill patients. N-acetyl-L-cysteine and its sulfhydryl metabolites could produce a false-positive result in the nitroprusside test for ketone bodies used in diabetes.24 N-acetyl-L-cysteine should be used with caution in those with a history of peptic ulcer disease since N-acetyl-L-cysteine may disrupt the gastric mucosal barrier.

Precautions: Allergies: Adverse reactions Allergic reactions have been reported following the use of oral L-methylfolate Calcium. Mild transient diarrhea, itching, transitory exanthema and the feeling of swelling of the entire body has been associated with methylcobalamin. Nausea, vomiting, diarrhea, transient skin rash, flushing, epigastric pain, and constipation have been associated with N-acetyl-L-cysteine.

Formula: Contains: Allergic reactions have been reported following the use of oral L-methylfolate Calcium. Mild transient diarrhea, itching, transitory exanthema and the feeling of swelling of the entire body has been associated with methylcobalamin. Nausea, vomiting, diarrhea, transient skin rash, flushing, epigastric pain, and constipation have been associated with N-acetyl-L-cysteine.

Directions: Recommended use The usual adult dose is one caplet daily or as directed under medical supervision.

Precautions: All Other: Use under medical supervision.

Storage: Storage Store at controlled room temperature 15(0)C to 30(0)C (59(0)F to 86(0)F) (See USP). Protect from heat, light and moisture.

Brand information

Manufactured and Distributed by: Alfasigma USA, Inc., Covington, LA